Omeros Corporation
OMERDrugs in Pipeline
13
Phase 3 Programs
4
Upcoming Catalysts
1
Next Catalyst
Dec 2026
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
How OMER's past catalysts played out
OMS103HP-S
Meniscal Tear
OMS302
Intraocular Lens Replacement
Phenylephrine HCl
Unilateral Cataract Extraction
OMS103HP
Anterior Cruciate Ligament Reconstruction
OMS302-PE
Cataract Extraction
OMS906
Paroxysmal Nocturnal Hemoglobinuria
OMS302 Solution
Cataract
Biological: narsoplimab
Thrombotic Microangiopathies
OMS643762
Schizophrenia
pioglitazone
Opioid Abuse
OMS201
Urinary Calculi
OMS721
Thrombotic Microangiopathies
OMS906 study drug
Paroxysmal Nocturnal Hemoglobinuria
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OMS103HP-S | Phase 3 | Meniscal Tear | - | - |
OMS302 | Phase 3 | Intraocular Lens Replacement | - | - |
Phenylephrine HCl | Phase 3 | Unilateral Cataract Extraction | - | - |
OMS103HP | Phase 3 | Anterior Cruciate Ligament Reconstruction | - | - |
OMS302-PE | Phase 2 | Cataract Extraction | - | - |
OMS906 | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
OMS302 Solution | Phase 2 | Cataract | - | - |
Biological: narsoplimab | Phase 2 | Thrombotic Microangiopathies | - | - |
OMS643762 | Phase 2 | Schizophrenia | - | - |
pioglitazone | Phase 2 | Opioid Abuse | - | - |
OMS201 | Phase 2 | Urinary Calculi | - | - |
OMS721 | Phase 2 | Thrombotic Microangiopathies | - | - |
OMS906 study drug | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Omeros Corporation's drug pipeline?→
CatalystAlert tracks 13 drug candidates in Omeros Corporation's (OMER) pipeline across Phase 3, Phase 2. Its lead program is OMS103HP-S (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Omeros Corporation's next FDA catalyst?→
Omeros Corporation's (OMER) next tracked catalyst is a Phase 2 expected December 15, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track OMER biotech catalysts?→
Add OMER to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Omeros Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.